Ertinob®
Product characteristics
Active substance: Erlotinib
Therapeutic group: Antineoplastic and immunomodulatory drugs. Antineoplastic drugs. Protein Kinase inhibitors. Tyrosine kinase inhibitors of the epidermal growth factor receptor (EGFR). Erlotinib. ATC CODE L01EB02
Form: 10 tablets each in a contour cell package. 3 contour cell packages in a cardboard pack with a hologram of the manufacturer.
Package Type: Film-coated tablets, 150 mg
Download instruction